Clinical Trials Browser

Phase 2 × Peritoneal Neoplasms × Docetaxel × Clear all

NCT01504256 2018-01-23

CatuNeo

Phase 2 Completed

Adenocarcinoma, Peritoneal Neoplasms

NCT00183794 2014-05-22

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Phase 2 Completed

20 enrolled 8 charts

Ovarian Neoplasms, Peritoneal Neoplasms